Edition:
United Kingdom

SCYNEXIS Inc (SCYX.OQ)

SCYX.OQ on NASDAQ Stock Exchange Global Market

1.69USD
25 Apr 2019
Change (% chg)

-- (--)
Prev Close
$1.69
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
186,361
52-wk High
$2.14
52-wk Low
$0.36

About

SCYNEXIS, Inc. is engaged in the discovery, development and commercialization of anti-infectives. The Company is developing its lead product candidate, SCY-078, as an oral and intravenous (IV) drug for the treatment of several fungal infections, including serious invasive fungal infections. SCY-078 is a structurally distinct... (more)

Overall

Beta: 0.40
Market Cap(Mil.): $65.20
Shares Outstanding(Mil.): 26.72
Dividend: --
Yield (%): --

Financials

  SCYX.OQ Industry Sector
P/E (TTM): -- 29.30 32.55
EPS (TTM): -0.98 -- --
ROI: -49.38 14.23 13.83
ROE: -62.87 15.46 15.25

Earnings vs. Estimates